Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | -1.61% | -6.15% | -47.41% |
Business Summary
Number of employees: 46
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Compounds
100.0
%
| 41 | 100.0 % | 49 | 100.0 % | +19.95% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 49 | 100.0 % | +19.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Eric Deng
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-30 |
Jason Sausser
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Richard Ghalie
CTO | Chief Tech/Sci/R&D Officer | 66 | 16-02-29 |
David Walsey
IRC | Investor Relations Contact | - | 18-01-31 |
Eugene Park
SAM | Sales & Marketing | - | 21-06-30 |
Anne Frese
HRO | Human Resources Officer | - | 22-06-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Nick Glover
BRD | Director/Board Member | 55 | 13-06-10 |
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Steven Wood
BRD | Director/Board Member | 41 | 23-10-30 |
Director/Board Member | 33 | 23-10-30 | |
James Flynn
BRD | Director/Board Member | 43 | 23-10-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 6,662,857 | 6,627,017 ( 99.46 %) | 0 | 99.46 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.41% | 20.65M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- MEIP Stock
- Company MEI Pharma, Inc.